Members |
acceptabilityId |
-2 |
Preferred (foundation metadata concept) |
-3 |
Preferred (foundation metadata concept) |
-4 |
Preferred (foundation metadata concept) |
-5 |
Preferred (foundation metadata concept) |
/10 min |
Preferred (foundation metadata concept) |
/12 t |
Preferred (foundation metadata concept) |
/24 t |
Preferred (foundation metadata concept) |
/30 min |
Preferred (foundation metadata concept) |
/40 |
Preferred (foundation metadata concept) |
/HPF |
Preferred (foundation metadata concept) |
/dag |
Preferred (foundation metadata concept) |
/ejakulat |
Preferred (foundation metadata concept) |
/minut |
Preferred (foundation metadata concept) |
/ml |
Preferred (foundation metadata concept) |
/mm3 |
Preferred (foundation metadata concept) |
/måned |
Preferred (foundation metadata concept) |
/periode |
Preferred (foundation metadata concept) |
/s |
Preferred (foundation metadata concept) |
/time |
Preferred (foundation metadata concept) |
/uge |
Preferred (foundation metadata concept) |
/µl |
Preferred (foundation metadata concept) |
/år |
Preferred (foundation metadata concept) |
0 |
Preferred (foundation metadata concept) |
0,010 inch |
Preferred (foundation metadata concept) |
0,012" |
Preferred (foundation metadata concept) |
0,014 inch |
Preferred (foundation metadata concept) |
0,016 inch |
Preferred (foundation metadata concept) |
0,018 inch |
Preferred (foundation metadata concept) |
0,022 inch |
Preferred (foundation metadata concept) |
0,06 opløsning med trypanblåt til oftalmisk anvendelse |
Preferred (foundation metadata concept) |
0,21 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,22 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,25 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,270 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,28 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,30 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,303 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,32 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,338 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,35 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,375 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,38 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,40 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,41 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,44 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,45 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,5 |
Preferred (foundation metadata concept) |
0,50 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,55 inch kuglekaliber |
Preferred (foundation metadata concept) |
0,60 inch kuglekaliber |
Preferred (foundation metadata concept) |
0-5 mitoser pr. 10 HPF (score = 1) |
Preferred (foundation metadata concept) |
0/5 |
Preferred (foundation metadata concept) |
0215/028 |
Preferred (foundation metadata concept) |
1 |
Preferred (foundation metadata concept) |
1 eller flere mitosefigurer pr. mm2 |
Preferred (foundation metadata concept) |
1 inch |
Preferred (foundation metadata concept) |
1 international enhed i 0,1 ml |
Preferred (foundation metadata concept) |
1 l skyllesprøjte af plast |
Preferred (foundation metadata concept) |
1 ml gradueret Portia-pipette |
Preferred (foundation metadata concept) |
1 standardafvigelse over middel |
Preferred (foundation metadata concept) |
1 standardafvigelse under middel |
Preferred (foundation metadata concept) |
1 tidligere graviditet |
Preferred (foundation metadata concept) |
1 time efter dosering |
Preferred (foundation metadata concept) |
1, hydroxycholecalciferol |
Acceptable (foundation metadata concept) |
1,2-alpha-L-fucosidase |
Preferred (foundation metadata concept) |
1,2-benzisothiazolin-3-on |
Preferred (foundation metadata concept) |
1,2-benzisothiazolin-3-one |
Preferred (foundation metadata concept) |
1,2-beta-fructan-1^F^-fructosyltransferase |
Preferred (foundation metadata concept) |
1,2-cyklisk inositolphosphat-phosphodiesterase |
Preferred (foundation metadata concept) |
1,2-diacylglycerol-3-beta-galactosyltransferase |
Preferred (foundation metadata concept) |
1,2-didehydropipecolatreduktase |
Preferred (foundation metadata concept) |
1,2-diphenyldiazen |
Preferred (foundation metadata concept) |
1,2-epoxybutan |
Preferred (foundation metadata concept) |
1,25-dihydroxyvitamin D3 |
Preferred (foundation metadata concept) |
1,3 mg strip med rose bengal |
Preferred (foundation metadata concept) |
1,3,5-tris(2-hydroxyethyl)-hexahydrotriazin |
Preferred (foundation metadata concept) |
1,3,5-tris(2-hydroxyethyl)-hexahydrotriazin |
Preferred (foundation metadata concept) |
1,3-Propandioldehydrogenase |
Preferred (foundation metadata concept) |
1,3-beta-glucan-phosphorylase |
Preferred (foundation metadata concept) |
1,3-beta-glukansyntase |
Preferred (foundation metadata concept) |
1,3-beta-glukansyntasemangel |
Preferred (foundation metadata concept) |
1,3-beta-oligoglucanphosphorylase |
Preferred (foundation metadata concept) |
1,3-dioxolan |
Preferred (foundation metadata concept) |
1,3-diphenylguanidin (DPG) |
Preferred (foundation metadata concept) |
1,4-alfa-glucan-forgrenenede enzym-mangel |
Preferred (foundation metadata concept) |
1,4-alpha-glucan-6-alpha-glucosyltransferase |
Preferred (foundation metadata concept) |
1,4-alpha-glucan-6alpha-glucosyltransferase-mangel |
Preferred (foundation metadata concept) |
1,4-beta-D-xylansynthase |
Preferred (foundation metadata concept) |
1,4-butanedioldiacrylat |
Preferred (foundation metadata concept) |
1,4-butanedioldiacrylat |
Preferred (foundation metadata concept) |
1,4-lactonase |
Preferred (foundation metadata concept) |
1,4-phenylenediamindihydrochlorid |
Preferred (foundation metadata concept) |
1,4-phenylenediamindihydrochlorid |
Preferred (foundation metadata concept) |
1,6-dihydroxycyclohexa-2,4-dien-1-carboxylatdehydrogenase |
Preferred (foundation metadata concept) |
1,6-hexamethylendiisocyanat |
Preferred (foundation metadata concept) |
1,6-hexamethylendiisocyanat |
Preferred (foundation metadata concept) |
1,6-hexanedioldiacrylat |
Preferred (foundation metadata concept) |
1,6-hexanedioldiacrylat |
Preferred (foundation metadata concept) |
1-(1-(2-thienyl)cyclohexyl)piperidin |
Preferred (foundation metadata concept) |
1-(4-isopropylphenyl)-3-phenyl-1,3-propandion |
Preferred (foundation metadata concept) |
1-12 anfald per år |
Preferred (foundation metadata concept) |